1. Lawsuit-ridden J&J tumbles in annual listing of best global brands — AstraZeneca gets Q2 2020 PDUFA date for breast cancer ADC — Shionogi's antibiotic clears FDA panel vote — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Medicare cuts felt in July

Discussion in 'Pacific Pulmonary Services' started by anonymous, Apr 4, 2016 at 10:28 AM.

  1. anonymous

    anonymous Guest

  2. anonymous

    anonymous Guest

    gulp and double gulp seems like unless you are really big you get the volume discount on concentrators and cpaps or if you are really small keeping it local with minimal costs you can survive. pps is neither
     
  3. anonymous

    anonymous Guest

    Price differentials from the big 02 and cpap vendors don't vary that much. Heck most big companies aren't buying any new equipment as thay struggle to move their old junk. THe biggest obstacle to the big companies which PPS is ( 3rg largest provider of E1403 to Medicare ). is the corporate office allowance. That line on the expense is where you will be paying for the know nothing ceo and entire regime of lackluster managers. The loans they are still paying for like the KY adventure in dumbness among other costly perks for the " home office " Weal management and planning are the bigger part of PPS struggles.